FATN vs. JAZZ
FATN (FatPipe, Inc) and JAZZ (Jazz Pharmaceuticals plc) are both stocks. FATN operates in Software - Infrastructure (Technology), while JAZZ operates in Biotechnology (Healthcare). Over the past year, FATN returned -38.43% vs 121.11% for JAZZ. At a 0.11 correlation, their price movements are largely independent.
Performance
FATN vs. JAZZ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FATN achieves a 164.85% return, which is significantly higher than JAZZ's 43.42% return.
FATN
- 1D
- -0.19%
- 1M
- -11.57%
- 6M
- 152.36%
- YTD
- 164.85%
- 1Y
- -38.43%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
JAZZ
- 1D
- -1.25%
- 1M
- 5.75%
- 6M
- 51.32%
- YTD
- 43.42%
- 1Y
- 121.11%
- 3Y*
- 24.24%
- 5Y*
- 5.79%
- 10Y*
- 5.54%
FATN vs. JAZZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
FATN FatPipe, Inc | 164.85% | -68.92% |
JAZZ Jazz Pharmaceuticals plc | 43.42% | 58.98% |
Correlation
The correlation between FATN and JAZZ is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2025 | 0.11 |
Fundamentals
FATN:
$75.04M
JAZZ:
$15.32B
FATN:
$0.08
JAZZ:
$0.47
FATN:
68.09
JAZZ:
519.97
FATN:
0.43
JAZZ:
33.80
FATN:
4.92
JAZZ:
3.45
FATN:
$15.13M
JAZZ:
$4.44B
FATN:
$13.71M
JAZZ:
$2.97B
FATN:
$2.19M
JAZZ:
$336.83M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FATN vs. JAZZ — Risk / Return Rank
FATN
JAZZ
FATN vs. JAZZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for FatPipe, Inc (FATN) and Jazz Pharmaceuticals plc (JAZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FATN | JAZZ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.44 | ||
| Sortino ratioReturn per unit of downside risk | -4.14 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.59 | -0.53 |
| Calmar ratioReturn relative to maximum drawdown | -0.51 | 10.29 | -10.80 |
| Martin ratioReturn relative to average drawdown | -0.72 | 25.44 | -26.16 |
Loading charts...
Drawdowns
FATN vs. JAZZ - Drawdown Comparison
The maximum FATN drawdown since its inception was -88.85%, smaller than the maximum JAZZ drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for FATN and JAZZ.
Loading charts...
Drawdown Indicators
| FATN | JAZZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.85% | -96.90% | +8.05% |
Max Drawdown (1Y)Largest decline over 1 year | -83.69% | -11.42% | -72.27% |
Max Drawdown (3Y)Largest decline over 3 years | — | -32.71% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -45.82% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -52.10% | — |
Current DrawdownCurrent decline from peak | -58.85% | -1.78% | -57.07% |
Average DrawdownAverage peak-to-trough decline | -60.73% | -27.28% | -33.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 60.18% | 4.61% | +55.57% |
Volatility
FATN vs. JAZZ - Volatility Comparison
FatPipe, Inc (FATN) has a higher volatility of 23.13% compared to Jazz Pharmaceuticals plc (JAZZ) at 7.23%. This indicates that FATN's price experiences larger fluctuations and is considered to be riskier than JAZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FATN | JAZZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.13% | 7.23% | +15.90% |
Volatility (6M)Calculated over the trailing 6-month period | 114.25% | 23.46% | +90.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 149.13% | 37.22% | +111.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 180.96% | 31.89% | +149.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 180.96% | 32.75% | +148.21% |
Dividends
FATN vs. JAZZ - Dividend Comparison
Neither FATN nor JAZZ has paid dividends to shareholders.
Financials
FATN vs. JAZZ - Financials Comparison
This section allows you to compare key financial metrics between FatPipe, Inc and Jazz Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
FATN vs. JAZZ - Profitability Comparison
FATN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, FatPipe, Inc reported a gross profit of 3.58M and revenue of 4.09M. Therefore, the gross margin over that period was 87.7%.
JAZZ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Jazz Pharmaceuticals plc reported a gross profit of 0.00 and revenue of 1.07B. Therefore, the gross margin over that period was 0.0%.
FATN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, FatPipe, Inc reported an operating income of 402.42K and revenue of 4.09M, resulting in an operating margin of 9.8%.
JAZZ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Jazz Pharmaceuticals plc reported an operating income of 336.60M and revenue of 1.07B, resulting in an operating margin of 31.5%.
FATN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, FatPipe, Inc reported a net income of 310.66K and revenue of 4.09M, resulting in a net margin of 7.6%.
JAZZ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Jazz Pharmaceuticals plc reported a net income of 293.10M and revenue of 1.07B, resulting in a net margin of 27.4%.
Frequently Asked Questions
FATN and JAZZ have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FATN has higher volatility (23.13%) compared to JAZZ (7.23%). In terms of maximum drawdown, FATN dropped -88.85% vs JAZZ's -96.90%.
JAZZ currently has the higher Sharpe Ratio (3.15 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FATN and JAZZ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer